SCHEDULE: Cinctive Capital Discloses 9.99% Stake in NeOnc Tech

Cinctive Capital Management LP and its affiliates have reported a 9.99% beneficial ownership stake in NeOnc Technologies Holdings, Inc. as of March 31, 2026.

Summary

• Cinctive Capital Management LP, Cinctive GP LLC, Richard H. Schimel, and Lawrence J. Sapanski filed a Schedule 13G indicating a 9.99% beneficial ownership in NeOnc Technologies Holdings, Inc.
• The total beneficial ownership of 2,483,980 shares includes 1,425,526 shares of common stock and 1,058,454 shares issuable upon the exercise of warrants.
• The holdings are subject to a 9.99% 'Blocker' provision, which prevents the reporting persons from exercising warrants that would result in ownership exceeding 9.99% of the outstanding common stock.
• The filing confirms that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory disclosure indicating institutional interest without signaling an intent to change corporate control.

Positives

• Institutional investment firm Cinctive Capital has established a significant 9.99% position, signaling confidence in the company's long-term prospects.

Negatives

• The ownership stake is capped at 9.99% via a 'Blocker' provision, limiting the immediate ability of the investor to increase their influence or stake without further regulatory notice.

Risks

• The investment is subject to a 9.99% ownership cap, which may limit the liquidity or strategic flexibility of the reporting persons regarding their position.
• The beneficial ownership calculation relies on the accuracy of the issuer's reported outstanding share count of 23,806,216 as of March 30, 2026.

Future Outlook

The reporting persons state that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Management Comments

• The reporting persons certify that the information set forth in the statement is true, complete, and correct to the best of their knowledge and belief.

Industry Context

StockSavvy.ai notes that the filing of a Schedule 13G by an investment firm like Cinctive Capital is a standard regulatory requirement for passive investors crossing the 5% ownership threshold, reflecting typical institutional portfolio management activity in the biotech/tech sector.

Comparison to Industry Standards

• The use of a 9.99% 'Blocker' provision is a standard mechanism in institutional investment agreements to avoid triggering regulatory requirements associated with becoming a 10% shareholder under the Securities Exchange Act.

Related Party Transactions

• Cinctive Global Master Fund, Ltd has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5 percent of the shares covered by this statement.

Stakeholder Impact

• Shareholders may view the entry of an institutional investor as a validation of the company's market position.

Next Steps

• The reporting persons may file amendments to this Schedule 13G if there are material changes in their percentage of ownership.

Key Dates

Keywords

NeOnc Technologies, Schedule 13G, Cinctive Capital, Beneficial Ownership, Institutional Investor, Common Stock